List view / Grid view
4 October 2016 | By Cisbio
A comprehensive line of ready-to-use HTRF toolbox reagents labeled with HTRF fluorescent dyes for studying molecular interactions using time-resolved fluorescence energy transfer...
4 October 2016 | By Cisbio
Rapid advancements have been made in understanding the key role epigenetic modifications play in regulating cell activity and their implications on cell health and disease progression...
4 October 2016 | By Cisbio
HTRF® cellular phospho-/total protein assays provide precise, sensitive measurement of endogeneous levels of phosphorylated and non phophorylated proteins able to be achieved in an endogenous cellular environment...
4 October 2016 | By Cisbio Bioassays
A line of high quality products have been developed, addressing biomarkers to meet the needs of multiple therapeutic areas such as inflammation, oncology, metabolic disease or CNS...
3 October 2016 | By Cisbio Bioassays
Cisbio Bioassays has supported GPCR investigation for many years regularly creating cutting edge assays and technologies suited to receptor characterization, compound screening and lead optimization...
Integrating the S3e™ Cell Sorter into sample preparation upstream of the QX200™ Droplet Digital System provided details about cell subpopulations that would have been undetectable in heterogeneous populations...
30 September 2016 | By Niamh Louise Marriott, Digital Content Producer
The AOPs are knowledge management tools in toxicology and are useful for supporting risk assessment to human health and to increase non-animal testing...
29 September 2016 | By Intellicyt
This webinar highlights the use of the iQue Screener for high-throughput screening of stem cells, small molecules and CRISPR functional screening, presented by David Sykes, M.D., Ph.D., Researcher from Massachusetts General Hospital and Thibault Jonckheere, CEO and Séverine Giltaire, Senior Scientist from ImmunXperts...
A new Bio-Plex Pro chemokine panel was validated for quantifying 40 human chemokines in one sample offering a significant advantage to researchers...
27 September 2016 | By Niamh Louise Marriott, Digital Content Producer
One example is the development of in vitro assays to enable the testing of 100 or so compounds per month for potential endocrine disrupting effects...
27 September 2016 | By Niamh Louise Marriott, Digital Content Producer
The Treponema pallidum assay is intended as an aid in the diagnosis of syphilis infection. The Roche Syphilis treponemal antibody test offers several...
26 September 2016 | By Charles River Laboratories
Partnership intends to accelerate translation of discoveries into novel therapies for patients...
Cisbio Bioassays has developed a GPCR platform based on the company’s HTRF® technology to measure second messenger accumulation...
20 September 2016 | By Drug Target Review
Drug Target Review talks to Joseph Zock, Senior Director of Product Management at IntelliCyt Corporation, to find out more about assay developments and future innovations in this area of drug discovery...
In vitro high-throughput cellular target-based assays are commonly used for hit identification targeting G-protein coupled receptors (GPCR). Agonist and antagonist identification of GPCRs often relies on the screening of large collections of chemicals using miniaturised in vitro cell-based functional assays. In the panel of assays, calcium mobilisation measured by aequorin…
